Dobutamine Hydrochloride

盐酸多巴酚丁胺

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameDobutamine Hydrochloride
Drug Alias Namedobutamina多马酚丁胺多巴胺多巴酚丁胺DobutaminumPosiject +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsTransthyretin amyloidosisHyperlactatemiaCoronary Disease +[12] 
Global Approved IndicationsHeart FailureHeart DiseasesShock, Septic
Approved Indications in ChinaHeart Diseases
Original Approved Country/TerritoryUnited States
Original Approved Date1978/07/18
Country/TerritoryCanadaUnited StatesDenmark +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Pharmaceutical Industry Co LtdFederal University Of Sao PauloUniversity Of Alberta +[8] 
Inactive CompaniesUniversity of Sao PauloEli Lilly And CompanyNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsTransthyretin amyloidosisHyperlactatemiaArrhythmias, Cardiac +[6] 
Inactive IndicationsCoronary DiseaseMyocardial IschemiaHeart Failure +[6] 

Other Information

ATC CodeC01CA07
Related LinksWikipediaDrugBankKEGG